Skip to content
MS
PW-010 Lipid Metabolism Catabolic unreviewed

Beta-Oxidation of Fatty Acids

Long-chain fatty acyl-CoA Acetyl-CoA + NADH + FADH2
Compartment
Mitochondrial matrix (peroxisome for VLCFA)
Main tissue
Liver, muscle, heart
Rate-limiting
Carnitine palmitoyltransferase I (CPT-1)
Steps
9

Reaction steps

In source order, 9 total

showing 1–9
  1. 1

    Fatty acid + CoA-SH + ATP → fatty acyl-CoA + AMP + PPi

    Notes

    A long-chain acyl-CoA synthetase (thiokinase) activates the fatty acid at the outer mitochondrial membrane/ER. ATP is converted to AMP and pyrophosphate; pyrophosphatase hydrolysis makes activation effectively irreversible and costs two ATP equivalents. This is necessary before transport or oxidation but is not the rate-limiting control point for long-chain oxidation.

  2. 2

    Fatty acyl-CoA + carnitine → acylcarnitine + CoA-SH

    Carnitine palmitoyltransferase I (CPT-1) 2.3.1.21 ST-0074 Irreversible/directional rate-limiting CoA-SH Carnitine
    Notes

    Carnitine palmitoyltransferase I (CPT-1), located on the outer mitochondrial membrane, transfers the acyl group to carnitine. This is the principal rate-limiting/regulatory step for mitochondrial oxidation of long-chain fatty acids and is inhibited by malonyl-CoA.

  3. 3

    Acylcarnitine (cytosolic side) → acylcarnitine (matrix side)

    Notes

    The inner-membrane carnitine–acylcarnitine translocase (CACT) exchanges incoming acylcarnitine for free carnitine moving outward. No ATP is directly consumed.

  4. 4

    Acylcarnitine + CoA-SH → fatty acyl-CoA + carnitine

    Notes

    Matrix-facing CPT-2 regenerates fatty acyl-CoA and free carnitine. Carnitine returns through CACT; CPT-1, CACT, and CPT-2 together constitute the carnitine shuttle.

  5. 5

    Fatty acyl-CoA + FAD → trans-Δ2-enoyl-CoA + FADH2

    Notes

    An acyl-CoA dehydrogenase catalyzes the first recurring oxidation. Very-long-, long-, medium-, or short-chain acyl-CoA dehydrogenase is selected by chain length; electrons pass from FADH2 through electron-transfer flavoprotein (ETF) and ETF:ubiquinone oxidoreductase to the ubiquinone pool. This is not directly ATP-producing but yields respiratory-chain reducing equivalents.

  6. 6

    trans-Δ2-Enoyl-CoA + H2O → L-3-hydroxyacyl-CoA

    Enoyl-CoA hydratase (crotonase) 4.2.1.17 ST-0078 Irreversible/directional H2O
    Notes

    Enoyl-CoA hydratase (crotonase) hydrates the double bond stereospecifically. No redox cofactor is required.

  7. 7

    L-3-Hydroxyacyl-CoA + NAD+ → 3-ketoacyl-CoA + NADH + H+

    L-3-hydroxyacyl-CoA dehydrogenase 1.1.1.35 ST-0079 Irreversible/directional NAD+ NADH
    Notes

    L-3-hydroxyacyl-CoA dehydrogenase oxidizes the β-hydroxyl group using NAD+. NADH donates electrons to complex I of the respiratory chain.

  8. 8

    3-Ketoacyl-CoA + CoA-SH → acetyl-CoA + fatty acyl-CoA shortened by two carbons

    Notes

    β-Ketothiolase (acyl-CoA acetyltransferase) performs thiolysis. The shortened acyl-CoA re-enters steps 5–8 until the chain is fully converted to acetyl-CoA; for an even-chain saturated fatty acid, the final thiolysis yields two acetyl-CoA molecules.

  9. 9

    Acetyl-CoA → CO2 in the tricarboxylic-acid cycle, or into ketogenesis in hepatic mitochondria

    Notes

    This is not a β-oxidation reaction itself, but it determines the ultimate ATP yield. Odd-chain fatty acids end with propionyl-CoA, which is carboxylated by propionyl-CoA carboxylase (biotin, ATP), rearranged via methylmalonyl-CoA, and converted by methylmalonyl-CoA mutase (adenosylcobalamin) to succinyl-CoA.

Showing all 9 steps.

Regulation

What speeds each enzyme up and what slows it down

CPT-1

Accelerated by

Low malonyl-CoA; increased fatty-acyl-CoA supply

Inhibited by

Malonyl-CoA (potent allosteric inhibitor)

Hormonal

Glucagon/epinephrine favor oxidation indirectly by lowering ACC activity and malonyl-CoA; insulin raises malonyl-CoA and restrains CPT-1

Long-chain acyl-CoA synthetase

Accelerated by

Fatty-acid availability; CoA and ATP

Inhibited by

Product acyl-CoA/limited CoA at high flux

Hormonal

Hormones primarily regulate substrate release rather than this enzyme directly

Acyl-CoA dehydrogenases (including MCAD)

Accelerated by

ADP demand, NAD+/FAD regeneration, substrate supply

Inhibited by

High NADH/NAD+ ratio; respiratory-chain impairment

Hormonal

Fasting hormones increase fatty-acid delivery; transcriptional control is mediated partly by PPARα in liver

ACC2 (muscle-associated isoform)

Accelerated by

Citrate; insulin signaling

Inhibited by

AMPK phosphorylation; long-chain acyl-CoAs

Hormonal

Insulin increases malonyl-CoA; exercise/AMPK lower malonyl-CoA and promote CPT-1 flux

Overview

Mitochondrial β-oxidation degrades fatty acyl-CoA molecules by sequential removal of two-carbon acetyl-CoA units, producing NADH and FADH2 for oxidative phosphorylation. It predominates during fasting, prolonged exercise, and carbohydrate restriction, especially in liver, heart, and oxidative skeletal muscle. The liver uses much of the resulting acetyl-CoA to support ketogenesis when oxaloacetate is diverted toward gluconeogenesis.

Cellular location

Activation occurs on the cytosolic face of the outer mitochondrial membrane and endoplasmic reticulum; long-chain acyl groups cross the inner mitochondrial membrane through the carnitine shuttle. The core spiral occurs in the mitochondrial matrix. Very-long-chain fatty acids are initially shortened by peroxisomal β-oxidation, whereas branched-chain fatty acids may require peroxisomal α-oxidation before further degradation.

Net energetics

For palmitate (16:0), seven cycles yield 8 acetyl-CoA, 7 NADH, and 7 FADH2. Complete oxidation yields approximately 108 ATP (8 acetyl-CoA × 10 ATP, 7 NADH × 2.5 ATP, and 7 FADH2 × 1.5 ATP) minus 2 ATP equivalents for activation, for a net 106 ATP using modern P/O ratios. Older conventions report 129 ATP by assigning 3 ATP per NADH and 2 ATP per FADH2.

Clinical significance

β-Oxidation is essential for maintaining ATP production during fasting and provides the acetyl-CoA that activates pyruvate carboxylase and supports gluconeogenesis. Failure of this pathway causes hypoketotic hypoglycemia because hepatic energy production and ketone-body formation both fail. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency classically presents in infancy or childhood with fasting intolerance, hypoketotic hypoglycemia, dicarboxylic aciduria, and risk of sudden death; management includes avoidance of prolonged fasting. CPT-1/CPT-2 and carnitine-transport defects similarly impair long-chain fatty-acid use.

Recent literature

Live Europe PMC search

Nothing is fetched until you ask, so the page stays fast and the request is yours rather than automatic.

Europe PMC · ten most recent, newest first